FDA has introduced a new program for medical devices and for device led combination products. Under this program are...
Results for "diagnostic technologies"
EMMA International’s Commitment to Supporting Early Detection Initiatives
Prostate cancer has emerged as the most commonly diagnosed cancer among men in the UK, with about 1 in 8 men affected during their lifetime. Early detection is vital as it significantly boosts survival rates and enhances treatment outcomes. Cutting-edge diagnostics, such as Oxford BioDynamics’ EpiSwitch PSE blood test—which boasts a remarkable 94% accuracy rate—are setting new standards in early prostate cancer diagnosis, outperforming traditional tests like the PSA.
EMMA International Launches Breast Cancer Awareness Month Educational Series
EMMA International Consulting Group, a life sciences consulting firm, announces the launch of an educational series in recognition of Breast Cancer Awareness Month. Throughout October, the series will explore how quality systems, regulatory strategy, and responsible innovation support the development of products used in breast cancer detection, diagnosis, and treatment.
Build a Business with Purpose Through EMMA International Franchising
Unlike traditional consumer-focused franchises, EMMA International provides professional consulting services to organizations across the life sciences industry. Our work supports companies throughout the product lifecycle, from early development and regulatory strategy to commercialization, manufacturing, quality management, and post-market compliance.
Automation & Robotics in the Lab of the Future
The lab of the future is not simply a collection of advanced instruments. It is a connected environment where people, automated systems, robotics, software, and quality processes work together. When implemented effectively, these technologies can reduce manual effort, improve data reliability, and allow laboratory personnel to focus on scientific analysis and higher-value decision-making.
Combination Product Compliance Challenges: Navigating Regulatory Complexity in Life Sciences
Unlike traditional pharmaceutical or medical device products, combination products must satisfy multiple regulatory frameworks simultaneously, requiring close collaboration between quality, regulatory affairs, engineering, manufacturing, and clinical teams. As regulatory agencies continue to emphasize quality systems, risk management, human factors, and lifecycle oversight, organizations must adopt integrated compliance strategies to successfully bring these products to market.
Global Regulatory Harmonization Challenges: Navigating Compliance in a Complex Global Landscape
Navigating compliance in a complex global landscape
Digital Traceability Is Becoming a Regulatory Expectation — Not a Competitive Advantage
Across regulated industries, digital traceability is no longer viewed as a strategic enhancement. It is quickly becoming a regulatory expectation. From pharmaceuticals and medical devices to aerospace, defense, and advanced manufacturing, oversight bodies are placing greater emphasis on transparency, data integrity, and real-time visibility into operations.
Software Engineer
Full Stack EngineerAre you passionate about AI and excited to build a platform from the ground up? EMMA International...
Healthcare’s Digital Transformation: Telemedicine, Data Protection, and Cybersecurity
Telemedicine has evolved from a supplemental offering into a foundational component of modern healthcare delivery. Virtual consultations, remote diagnostics, and digital patient engagement have improved access to care, reduced logistical barriers, and supported continuity across care settings. These technologies have become especially valuable in addressing workforce shortages and extending care to underserved populations.









